chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Headache
Clinical narrative: back is hurting; headache; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back is hurting) and HEADACHE (headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B1A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced BACK PAIN (back is hurting) and HEADACHE (headache). At the time of the report, BACK PAIN (back is hurting) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (dizziness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) at a dose of 1 dosage form. At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old given the 1st dose of vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old given the 1st dose of vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old given the 1st dose of vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old given the 1st dose of vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  No other treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Additional information received included no new information.; Sender's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273, lot #046A21A with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: General side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (General side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (General side effects). At the time of the report, VACCINATION COMPLICATION (General side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow up received on 08-MAY-2021. It contains NNI.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: Arm swollen; Redness; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swollen), ERYTHEMA (Redness) and PRURITUS (Itchiness) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATENOLOL, AMLODIPINE, MIRABEGRON (MYRBETRIQ), TRAMADOL, ROSUVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), CALCIUM, ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) and DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID, TOCOPHEROL (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHEROL]) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm swollen), ERYTHEMA (Redness) and PRURITUS (Itchiness). At the time of the report, PERIPHERAL SWELLING (Arm swollen), ERYTHEMA (Redness) and PRURITUS (Itchiness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication provided also include Omega. Treatment information was not provided. The patient reports that she is completely fine now.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received 09 May 2021 included events outcome.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Illness, Insomnia, Paraesthesia
Clinical narrative: has only been getting worse by the day; keeps her up at night and she cannot sleep; sick, very sick for the first 24 hours; Initial serious tingling in her entire body and face, face her nose her arms are tingling; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Initial serious tingling in her entire body and face, face her nose her arms are tingling), CONDITION AGGRAVATED (has only been getting worse by the day), INSOMNIA (keeps her up at night and she cannot sleep) and ILLNESS (sick, very sick for the first 24 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PARAESTHESIA (Initial serious tingling in her entire body and face, face her nose her arms are tingling). On an unknown date, the patient experienced CONDITION AGGRAVATED (has only been getting worse by the day), INSOMNIA (keeps her up at night and she cannot sleep) and ILLNESS (sick, very sick for the first 24 hours). At the time of the report, PARAESTHESIA (Initial serious tingling in her entire body and face, face her nose her arms are tingling), CONDITION AGGRAVATED (has only been getting worse by the day), INSOMNIA (keeps her up at night and she cannot sleep) and ILLNESS (sick, very sick for the first 24 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. Concomitant medications were not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Warm to the touch at the site of injection; Itchy at the site of injection; A rash at the site of injection; Red at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection), VACCINATION SITE RASH (A rash at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection), VACCINATION SITE RASH (A rash at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection), VACCINATION SITE RASH (A rash at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were provided. No concomitant medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow-up received provided no new information.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Pyrexia
Clinical narrative: nose dripping; cough after receiving the Moderna vaccine; headache; fatigue; fever 101.9; chills; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (nose dripping), COUGH (cough after receiving the Moderna vaccine), HEADACHE (headache), FATIGUE (fatigue) and PYREXIA (fever 101.9) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced RHINORRHOEA (nose dripping), COUGH (cough after receiving the Moderna vaccine), HEADACHE (headache), FATIGUE (fatigue), PYREXIA (fever 101.9) and CHILLS (chills). At the time of the report, RHINORRHOEA (nose dripping), COUGH (cough after receiving the Moderna vaccine), HEADACHE (headache), FATIGUE (fatigue), PYREXIA (fever 101.9) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-052012 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-052012:patient case
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: nose dripping; cough after receiving the Moderna vaccine; headache; fatigue; fever 101.9; chills; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (nose dripping), COUGH (cough after receiving the Moderna vaccine), HEADACHE (headache), FATIGUE (fatigue) and PYREXIA (fever 101.9) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced RHINORRHOEA (nose dripping), COUGH (cough after receiving the Moderna vaccine), HEADACHE (headache), FATIGUE (fatigue), PYREXIA (fever 101.9) and CHILLS (chills). At the time of the report, RHINORRHOEA (nose dripping), COUGH (cough after receiving the Moderna vaccine), HEADACHE (headache), FATIGUE (fatigue), PYREXIA (fever 101.9) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-052012 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-052012:patient case
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling on her arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on her arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced PARAESTHESIA (Tingling on her arm). At the time of the report, PARAESTHESIA (Tingling on her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 3 days later after first dose received the second dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 days later after first dose received the second dose) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 days later after first dose received the second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 days later after first dose received the second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications was reported.  No treatment information was provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-JUNE-2021 and contains no newinformation; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Unknown) with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a physician and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Immunosuppression. Concomitant products included TACROLIMUS (PROGRAF) and MYCOPHENOLATE MOFETIL HYDROCHLORIDE (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]) for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Redness at injection site; Itching at injection site; Swelling at injection site; Bruising around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE BRUISING (Bruising around injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE BRUISING (Bruising around injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE BRUISING (Bruising around injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental exposure to product, Device connection issue, Underdose
Clinical narrative: Did not feel patient received full dose; He realized the needle separated from syringe; Patient felt a spray on her arm; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of UNDERDOSE (Did not feel patient received full dose), DEVICE CONNECTION ISSUE (He realized the needle separated from syringe) and ACCIDENTAL EXPOSURE TO PRODUCT (Patient felt a spray on her arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 immunisation.     The patient's past medical history included No adverse event (No reported medical history.).    On 19-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 19-Mar-2021, the patient experienced UNDERDOSE (Did not feel patient received full dose), DEVICE CONNECTION ISSUE (He realized the needle separated from syringe) and ACCIDENTAL EXPOSURE TO PRODUCT (Patient felt a spray on her arm). On 19-Mar-2021, UNDERDOSE (Did not feel patient received full dose), DEVICE CONNECTION ISSUE (He realized the needle separated from syringe) and ACCIDENTAL EXPOSURE TO PRODUCT (Patient felt a spray on her arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Pyrexia
Clinical narrative: bone ache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone ache), PYREXIA (fever) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced BONE PAIN (bone ache), PYREXIA (fever) and CHILLS (chills). At the time of the report, BONE PAIN (bone ache), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Peripheral coldness, Tremor
Clinical narrative: weakness; hands are cold an clammy; cannot stop shaking; cough; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), PERIPHERAL COLDNESS (hands are cold an clammy), TREMOR (cannot stop shaking) and COUGH (cough) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included nexium and ORPHENADRINE CITRATE (FLEXOR [ORPHENADRINE CITRATE]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), PERIPHERAL COLDNESS (hands are cold an clammy), TREMOR (cannot stop shaking) and COUGH (cough). At the time of the report, ASTHENIA (weakness), PERIPHERAL COLDNESS (hands are cold an clammy), TREMOR (cannot stop shaking) and COUGH (cough) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs taken are Nexium and flexor-75mg. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up information received on 08-MAY-2021 contains No New Information.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Peripheral swelling
Clinical narrative: Shoulder pain; woke up with the double size if the shoulder; can not lift my arm because of the terrible pain, i have to help that arm with the left one¨; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (woke up with the double size if the shoulder), MOBILITY DECREASED (can not lift my arm because of the terrible pain, i have to help that arm with the left one¨) and ARTHRALGIA (Shoulder pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure fluctuation.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PERIPHERAL SWELLING (woke up with the double size if the shoulder) and MOBILITY DECREASED (can not lift my arm because of the terrible pain, i have to help that arm with the left one¨). On 19-Mar-2021, the patient experienced ARTHRALGIA (Shoulder pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (woke up with the double size if the shoulder), MOBILITY DECREASED (can not lift my arm because of the terrible pain, i have to help that arm with the left one¨) and ARTHRALGIA (Shoulder pain) outcome was unknown.            No concomitant medications were reported. Action taken with mRNA-1273 in response to events was not applicable.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Skin exfoliation, Vaccination site erythema, Vaccination site pain, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Alligator like skin; Right arm was swollen; R arm was reddened; R amr covid arm; Sore arm on the day after the vaccine; Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Alligator like skin), VACCINATION SITE REACTION (R amr covid arm), VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine), VACCINATION SITE PAIN (Sore arm on the day after the vaccine) and VACCINATION SITE SWELLING (Right arm was swollen) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Graves' disease since September 2016. Concomitant products included METHIMAZOLE, ATENOLOL, VITAMIN D NOS and VITAMIN B12 NOS for Graves' disease.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine). On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm on the day after the vaccine). On 19-Mar-2021, the patient experienced VACCINATION SITE REACTION (R amr covid arm). On an unknown date, the patient experienced SKIN EXFOLIATION (Alligator like skin). an unknown date, the patient experienced VACCINATION SITE SWELLING (Right arm was swollen) and VACCINATION SITE ERYTHEMA (R arm was reddened). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 28-Mar-2021, VACCINATION SITE REACTION (R amr covid arm) had resolved. At the time of the report, SKIN EXFOLIATION (Alligator like skin), VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine), VACCINATION SITE SWELLING (Right arm was swollen) and VACCINATION SITE ERYTHEMA (R arm was reddened) outcome was unknown and VACCINATION SITE PAIN (Sore arm on the day after the vaccine) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up received on 08-May-2021 contains updated information of patient initials, pregnancy information, second dose details of suspect product, action taken with suspect product and additional non-serious events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: Alligator like skin; Right arm was swollen; R arm was reddened; R amr covid arm; Sore arm on the day after the vaccine; Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Alligator like skin), VACCINATION SITE REACTION (R amr covid arm), VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine), VACCINATION SITE PAIN (Sore arm on the day after the vaccine) and VACCINATION SITE SWELLING (Right arm was swollen) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Graves' disease since September 2016. Concomitant products included METHIMAZOLE, ATENOLOL, VITAMIN D NOS and VITAMIN B12 NOS for Graves' disease.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine). On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm on the day after the vaccine). On 19-Mar-2021, the patient experienced VACCINATION SITE REACTION (R amr covid arm). On an unknown date, the patient experienced SKIN EXFOLIATION (Alligator like skin). an unknown date, the patient experienced VACCINATION SITE SWELLING (Right arm was swollen) and VACCINATION SITE ERYTHEMA (R arm was reddened). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 28-Mar-2021, VACCINATION SITE REACTION (R amr covid arm) had resolved. At the time of the report, SKIN EXFOLIATION (Alligator like skin), VACCINATION SITE URTICARIA (Large big red welt on arm after receiving her first dose of the Moderna COVID-19 vaccine), VACCINATION SITE SWELLING (Right arm was swollen) and VACCINATION SITE ERYTHEMA (R arm was reddened) outcome was unknown and VACCINATION SITE PAIN (Sore arm on the day after the vaccine) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up received on 08-May-2021 contains updated information of patient initials, pregnancy information, second dose details of suspect product, action taken with suspect product and additional non-serious events.
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on arm, leg) and PRURITUS (itching) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced RASH (rash on arm, leg) and PRURITUS (itching). At the time of the report, RASH (rash on arm, leg) and PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain
Clinical narrative: The pain is now in the left side only; muscle and joint pain and a pain that started in her back and went down to both of her legs; muscle and joint pain and a pain that started in her back and went down to both of her legs; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle and joint pain and a pain that started in her back and went down to both of her legs), PAIN (The pain is now in the left side only) and ARTHRALGIA (muscle and joint pain and a pain that started in her back and went down to both of her legs) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Kidney disorder.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced MYALGIA (muscle and joint pain and a pain that started in her back and went down to both of her legs) and ARTHRALGIA (muscle and joint pain and a pain that started in her back and went down to both of her legs). On an unknown date, the patient experienced PAIN (The pain is now in the left side only). At the time of the report, MYALGIA (muscle and joint pain and a pain that started in her back and went down to both of her legs), PAIN (The pain is now in the left side only) and ARTHRALGIA (muscle and joint pain and a pain that started in her back and went down to both of her legs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and PARACETAMOL (TYLENOL) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN (pain). At the time of the report, PAIN (pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Urticaria, Vaccination site urticaria
Clinical narrative: itching; small bumps like mild hives on the lower back and at the injection site in the left arm; small bumps like mild hives on the lower back and at the injection site in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), URTICARIA (small bumps like mild hives on the lower back and at the injection site in the left arm) and VACCINATION SITE URTICARIA (small bumps like mild hives on the lower back and at the injection site in the left arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PRURITUS (itching), URTICARIA (small bumps like mild hives on the lower back and at the injection site in the left arm) and VACCINATION SITE URTICARIA (small bumps like mild hives on the lower back and at the injection site in the left arm). At the time of the report, PRURITUS (itching), URTICARIA (small bumps like mild hives on the lower back and at the injection site in the left arm) and VACCINATION SITE URTICARIA (small bumps like mild hives on the lower back and at the injection site in the left arm) outcome was unknown. Not Provided          No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: gout; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (gout) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included Gout.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GOUT (gout). At the time of the report, GOUT (gout) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Circadian rhythm sleep disorder, Insomnia
Clinical narrative: jetlag comes 100; not been sleeping; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (not been sleeping) and CIRCADIAN RHYTHM SLEEP DISORDER (jetlag comes 100) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced INSOMNIA (not been sleeping). On an unknown date, the patient experienced CIRCADIAN RHYTHM SLEEP DISORDER (jetlag comes 100). At the time of the report, INSOMNIA (not been sleeping) and CIRCADIAN RHYTHM SLEEP DISORDER (jetlag comes 100) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Appointment had to be postponed; A spontaneous report was received from a consumer concerning a female patient of unknown age, who received Moderna's COVID-19 vaccine(mRNA-1273) and appointment had to be postponed (product dose omission).  The patient's medical history was not provided. No relevant Concomitant medications were reported.  On 28 Jan 2021, prior to the onset of event, the patient received her first of the two planned vaccine doses of mRNA-1273(Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 25 Feb 2021, the patient was scheduled to receive the second dose, but a death in the family occurred and the appointment had to be postponed.   No treatment information was provided.  Action taken with the mRNA-1273 in response to the event was not reported.  The outcome of the event, appointment had to be postponed, was considered recovered; Reporter's Comments: This report refers to a case of Product dose omission, for mRNA-1273, lot #: unknown,  with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Malaise, Rash erythematous
Clinical narrative: wave sensations in head; headache; blotchy red rash on face; felt really sick; tired/fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (blotchy red rash on face), MALAISE (felt really sick), FEELING ABNORMAL (wave sensations in head), FATIGUE (tired/fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced MALAISE (felt really sick) and FATIGUE (tired/fatigue). On 18-Mar-2021, the patient experienced RASH ERYTHEMATOUS (blotchy red rash on face). On 19-Mar-2021, the patient experienced FEELING ABNORMAL (wave sensations in head) and HEADACHE (headache). On 16-Mar-2021, MALAISE (felt really sick) and FATIGUE (tired/fatigue) had resolved. At the time of the report, RASH ERYTHEMATOUS (blotchy red rash on face), FEELING ABNORMAL (wave sensations in head) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were no provided by  the reporter.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Ear discomfort, Headache, Myalgia
Clinical narrative: Ears stuffed up; Aches; Chills; Headache; Fever 100.1F; This spontaneous case was reported by a nurse and describes the occurrence of EAR DISCOMFORT (Ears stuffed up), MYALGIA (Aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever 100.1F) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced EAR DISCOMFORT (Ears stuffed up), MYALGIA (Aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever 100.1F). In February 2021, EAR DISCOMFORT (Ears stuffed up), MYALGIA (Aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever 100.1F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 100.1 (Inconclusive) Fever 100.1F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Ears stuffed up; Aches; Chills; Headache; Fever 100.1F; This spontaneous case was reported by a nurse and describes the occurrence of EAR DISCOMFORT (Ears stuffed up), MYALGIA (Aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever 100.1F) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced EAR DISCOMFORT (Ears stuffed up), MYALGIA (Aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever 100.1F). In February 2021, EAR DISCOMFORT (Ears stuffed up), MYALGIA (Aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever 100.1F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 100.1 (Inconclusive) Fever 100.1F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on both insides of arms/ rash on top of legs/ rash on belly/rash on back; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on both insides of arms/ rash on top of legs/ rash on belly/rash on back) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 010A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included EMPAGLIFLOZIN (JARDIANCE), ROSUVASTATIN, METFORMIN, ROSUVASTATIN CALCIUM (CRESTOR), TOCOPHERYL ACETATE (LANTUROL), ACETYLSALICYLIC ACID (BABY ASPIRIN), COLECALCIFEROL (VITAMIN D 3) and RAMIPRIL for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash on both insides of arms/ rash on top of legs/ rash on belly/rash on back). At the time of the report, RASH (rash on both insides of arms/ rash on top of legs/ rash on belly/rash on back) outcome was unknown.            Treatment included benadryl cream  Approximately 27-Feb-2021, patient developed a rash on both insides of arms, top of legs, belly and back 2 weeks.The rash comes and goes getting lighter and then darker and is sometimes scaly.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Lymphadenopathy, Pain in extremity
Clinical narrative: Swollen lymph node near right arm; Diarrhea; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (Diarrhea), PAIN IN EXTREMITY (Pain in arm) and LYMPHADENOPATHY (Swollen lymph node near right arm) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced DIARRHEA (Diarrhea) and PAIN IN EXTREMITY (Pain in arm). On 08-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph node near right arm). On 27-Feb-2021, DIARRHEA (Diarrhea) and PAIN IN EXTREMITY (Pain in arm) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph node near right arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications was provided.  No treatment information was provided.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Malaise, Nasal congestion
Clinical narrative: Body chills; Cough; Fever; Nausea; Headache; Started to not feel well; Stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose), MALAISE (Started to not feel well), COUGH (Cough), PYREXIA (Fever) and NAUSEA (Nausea) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type I diabetes mellitus. Concomitant products included INSULIN for Type I diabetes mellitus.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced NASAL CONGESTION (Stuffy nose). On 17-Mar-2021, the patient experienced MALAISE (Started to not feel well), NAUSEA (Nausea) and HEADACHE (Headache). On 18-Mar-2021, the patient experienced COUGH (Cough) and PYREXIA (Fever). On an unknown date, the patient experienced CHILLS (Body chills). At the time of the report, NASAL CONGESTION (Stuffy nose), MALAISE (Started to not feel well), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Body chills) outcome was unknown, COUGH (Cough) had not resolved and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications taken were cough syrup.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Body chills; Cough; Fever; Nausea; Headache; Started to not feel well; Stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose), MALAISE (Started to not feel well), COUGH (Cough), PYREXIA (Fever) and NAUSEA (Nausea) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type I diabetes mellitus. Concomitant products included INSULIN for Type I diabetes mellitus.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced NASAL CONGESTION (Stuffy nose). On 17-Mar-2021, the patient experienced MALAISE (Started to not feel well), NAUSEA (Nausea) and HEADACHE (Headache). On 18-Mar-2021, the patient experienced COUGH (Cough) and PYREXIA (Fever). On an unknown date, the patient experienced CHILLS (Body chills). At the time of the report, NASAL CONGESTION (Stuffy nose), MALAISE (Started to not feel well), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Body chills) outcome was unknown, COUGH (Cough) had not resolved and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications taken were cough syrup.